546 Study guides, Class notes & Summaries

Test Bank for Behavior Modification What It Is and How to Do It 11th Edition Martin and Pear 1.A behavioral deficit is: *a) too little of a particular type of behavior b)too much of a particular type of behavior c)an appropriate behavior occurring to the wrong stimulus d)an appropriate behav...

NR 546 WEEK 7 ADHD Medication Table (Updated). Methylphenidate (D/L) (Concerta, Ritalin) -Dopamine, norepinephrine inhibitor and releaser (DNRIRe), stimulant, FDA approved for ADHD in children and adults (ages vary based on formulations), narcolepsy. Off-label for treatmentresistant depression. Enhancement DA and NE in certain areas of the brain (dorsolateral prefrontal cortex, medial prefrontal cortex). Primary target symptoms: concentration, attention span, motor hyperactivity,...

Chamberlain NR 546 Week 5 Antidepressant and Mood Stabilizer Medication Table

NR 546 WEEK 1 Quiz TO Week 6 Quiz with Accurate answers NR546 WEEK 1 The amygdala is associated with anxiety and perception of odors. The hippocampus is involved in memory and anxiety. The amygdala is associated with anxiety and perception of odors. The prefrontal cortex is associated with executive function. The thalamus is associated with motor command processing The client’s cognitive status can result in an ethical concern if the client is unable to self-determine care or is a danger to se...

NR546 NR 546 PSYCHOPHARM MIDTERM EXAM QUESTIONS AND CORRECT ANSWERS 2024/2025 GRADED A+. 2 / 11 1. How does the orbitofrontal cortex (OFC) affect the amygdala?: inhibits andactivates the amygdala 2. Wernicke's area is associated with which of the following?:speech compre-hension 3. The limbic system is associated with which of the following: emotion andlearning 4. Which brain structure is most associated with long term memory?: hip-pocampus 5. When prescribing psychotropic medications...

Final Exam: NR546/ NR 546 Psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner Final Exam | Questions and Verified Answers| Latest Update 2023/ 2024 |Chamberlain Q: What antidepressant has the longest half life? Answer: fluoxetine Q: What antidepressant also treats social anxiety and insomnia Answer: paroxetine Q: What antidepressant treats anxious depression smokers require increased do...

NR 546 Week 7 ADHD Medication Table Latest. Drug Name (include if IR, XR, ODT, LA) Indication (include approved ages) Neurotransmitter(s) Affected Target Symptoms Short-acting, intermediate-acting or long-acting. Duration of action, peak (if noted) Notable side effects /Patient education instructions Methylphenidate (D/L) (Concerta, Ritalin) Indication (include approved ages) Attention deficit hyperactivity disorder (ADHD) in children and adults (approved ages vary base...

RSK4804 Assignment 2 2024 (Unique Nr. 546572) - DUE 28 June 2024 ;100 % TRUSTED workings, explanations and solutions. For assistance call or W.h.a.t.s.a.p.p us on ...(.+.2.5.4.7.7.9.5.4.0.1.3.2)........... Question 1 (5) (a) What do you understand by the probability of default? (b) Maseru Development Bank has R850 million credit with Matsieng Hydroelectric Power, with a maturity of eighteen months. The expected loss for Maseru Development Bank is R22 million, and the recovery rate is ...

NR546 / NR 546 ACTUAL MIDTERM EXAM 2023 QUESTIONS AND ANSWERS What should the PMHNP consider when prescribing chemical restraints? - Answer-- allergy status -prior med hx for adverse drug reactions r/t the meds ordered in the chemical restraint -state regulations regarding chemical restrains must be reviewed Are the PMHNP and other staff liable if the client has an allergic reaction or adverse side effects to the drugs used for chemical restraint? - Answer-No. The client has been court-ordered t...

Final Exam: NR546/ NR 546 Psychopharmacology for the Psychiatric- Mental Health Nurse Practitioner Final Exam Review | Complete Guide Questions and Verified Answers| 2023/ 2024!! |Chamberlain QUESTION Paroxetine warning Answer: this antidepressant has the highest risk of discontinuation syndrome d/t serotonin transporter inhibition and anticholinergic rebound. If treatment course has lasted 8 weeks, discontinue over 1-2 weeks. QUESTION serotonin syndrome Ans...